"10.1371_journal.pmed.1001481","plos medicine","2013-07-09T00:00:00Z","Clare Oliver-Williams; Michael Fleming; Kirsten Monteath; Angela M Wood; Gordon C S Smith","Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Information Services Division, NHS National Services Scotland, Edinburgh, United Kingdom; Department of Obstetrics and Gynaecology, National Institute for Health Research Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom","Â¶ These authors are joint senior authors on this work.","GCSS is a member of the Editorial Board of PLOS Medicine. GCSS has acted as a paid consultant to GSK around therapeutic approaches to preterm birth. GCSS is named on a US patent (US61/253936) for the administration of paraoxonase 3 to preterm human infants as a therapeutic product. The authors have declared there are no other competing interests.","2013","07","Clare Oliver-Williams","COW",5,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
